These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31433121)

  • 1. Probing Binding Landscapes and Molecular Recognition Mechanisms of Atypical Antipsychotic Drugs towards the Selective Targeting of D
    Appiah-Kubi P; Olotu FA; Soliman MES
    Mol Inform; 2019 Nov; 38(11-12):e1900044. PubMed ID: 31433121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone.
    Wang S; Che T; Levit A; Shoichet BK; Wacker D; Roth BL
    Nature; 2018 Mar; 555(7695):269-273. PubMed ID: 29466326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Main interactions of dopamine and risperidone with the dopamine D2 receptor.
    Martínez A; García-Gutiérrez P; Zubillaga RA; Garza J; Vargas R
    Phys Chem Chem Phys; 2021 Jul; 23(26):14224-14230. PubMed ID: 34159983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol bound D
    Fan L; Tan L; Chen Z; Qi J; Nie F; Luo Z; Cheng J; Wang S
    Nat Commun; 2020 Feb; 11(1):1074. PubMed ID: 32103023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane.
    Yin J; Chen KM; Clark MJ; Hijazi M; Kumari P; Bai XC; Sunahara RK; Barth P; Rosenbaum DM
    Nature; 2020 Aug; 584(7819):125-129. PubMed ID: 32528175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R).
    Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M
    J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Binding Geometries for Risperidone in Dopamine D3 Receptors: Insights on the Fast-Off Mechanism through Docking, Quantum Biochemistry, and Molecular Dynamics Simulations.
    Zanatta G; Della Flora Nunes G; Bezerra EM; da Costa RF; Martins A; Caetano EW; Freire VN; Gottfried C
    ACS Chem Neurosci; 2016 Oct; 7(10):1331-1347. PubMed ID: 27434874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor.
    Hjerde E; Dahl SG; Sylte I
    Eur J Med Chem; 2005 Feb; 40(2):185-94. PubMed ID: 15694653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomistic molecular dynamics simulations of typical and atypical antipsychotic drugs at the dopamine D2 receptor (D2R) elucidates their inhibition mechanism.
    Salmas RE; Yurtsever M; Durdagi S
    J Biomol Struct Dyn; 2017 Mar; 35(4):738-754. PubMed ID: 26923489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the structural impact of S311C mutation in DRD2 receptor by molecular dynamics & docking studies.
    Podder A; Pandey D; Latha N
    Biochimie; 2016 Apr; 123():52-64. PubMed ID: 26805384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study.
    Bressan RA; Erlandsson K; Jones HM; Mulligan RS; Ell PJ; Pilowsky LS
    J Clin Psychopharmacol; 2003 Feb; 23(1):5-14. PubMed ID: 12544369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of the 5-HT
    Kimura KT; Asada H; Inoue A; Kadji FMN; Im D; Mori C; Arakawa T; Hirata K; Nomura Y; Nomura N; Aoki J; Iwata S; Shimamura T
    Nat Struct Mol Biol; 2019 Feb; 26(2):121-128. PubMed ID: 30723326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
    Zhang JP; Robinson DG; Gallego JA; John M; Yu J; Addington J; Tohen M; Kane JM; Malhotra AK; Lencz T
    Schizophr Bull; 2015 Nov; 41(6):1248-55. PubMed ID: 26320194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking Screens of Noncovalent Interaction Motifs of the Human Subtype-D2 Receptor-75 Schizophrenia Antipsychotic Complexes with Physicochemical Appraisal of Antipsychotics.
    Amani P; Habibpour R; Karami L; Hofmann A
    ACS Chem Neurosci; 2021 Jun; 12(12):2218-2232. PubMed ID: 34061513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chronic antipsychotic drug on hypothalamic expression of neural nitric oxide synthase and dopamine D2 receptor in the male rat.
    Zhang XR; Wang YX; Zhang ZJ; Li L; Reynolds GP
    PLoS One; 2012; 7(4):e33247. PubMed ID: 22514604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications.
    Zhang Y; Yu JG; Wen W
    Eur J Med Chem; 2024 Nov; 277():116731. PubMed ID: 39098130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling.
    Brust TF; Hayes MP; Roman DL; Watts VJ
    Biochem Pharmacol; 2015 Jan; 93(1):85-91. PubMed ID: 25449598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-directed bias of G protein signaling at the dopamine D
    Von Moo E; Harpsøe K; Hauser AS; Masuho I; Bräuner-Osborne H; Gloriam DE; Martemyanov KA
    Cell Chem Biol; 2022 Feb; 29(2):226-238.e4. PubMed ID: 34302750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.